The main immunophenotype markers in T-ALL include terminal deoxynucleotidyl transferase (TdT) and CD3, with other markers, such as CD1a, CD2, CD4, CD5, CD7, and CD8, being variably expressed [4]. Here, DNTT is linked to acute lymphoblastic leukemia.